Prescription Avodart (generic name Dutasteride) is an FDA approved treatment for Benign Prostatic Hyperplasia, or BPH, commonly known as an enlarged prostate. It was developed in the late 1990's and is currently used by millions of men who suffer this condition, which is rather common but not in any way directly linked to prostate cancer.
Symptoms of BPH include frequent urination, dribbling, and interrupted urinations. An enlarged prostate gland presses against the bladder, a condition usually not affecting men until about 40 years of age or older. Symptoms of prostate cancer are similar, therefore it is important to see a physician if symptoms persist, in order to determine the actual cause.
Medications to relieve the symptoms and discomfort do so by blocking the enzyme that normally would convert Testosterone into Dihydrotestosterone, or DHT. This results in an actual shrinkage of the prostate itself. Avodart is is one of these pharmaceuticals prescribed for the treatment of an enlarged prostate. In almost all laboratory studies conducted, Avodart has been shown to inhibit DHT for a longer period of time than earlier forms of prescription Dutasteride.
Avodart is available as a 0.5 milligram softgel, and is taken orally, as prescribed by a physician. Side effects appear to be minor, and may include slight breast enlargement or tenderness, a degree of impotence, somewhat decreased libido, and difficulty in ejaculation. Most do not experience these side effects; generally less than 3% of men tested reported any degree of the conditions mentioned.
Another possible benefit of Dutasteride is the stoppage or even reversal of hair loss, not only among men, but women as well. There have been a number of studies that conclude the positive results of Avodart when used to treat the hair loss disorder. FDA approval of this form of Dutasteride was put on hold, apparently for reasons dealing with the probable cost of the drug when used for this purpose, namely concerns over whether the market was viable in terms of sales volume.
Although considered a medical success, Avodart and other Dual 5-alpha Reductase inhibitors continue to be studied under laboratory conditions. It has been tentatively concluded that no long term side-disorders arise, and patients are almost always satisfied with their results. However, talking to a physician is the best way to determine if Avodart is the right choice when suffering urinary problems. Testing for an enlarged protate is a very simple procedure, and it may well be that Avodart is the most effective treatment to be recommended.
It's already activated!